Trial intelligence / Profile preview

Hepatitis B vaccine effectiveness in children prenatally exposed to anti-TNF

NL-OMON20411Recruiting

Sponsor
Erasmus MC
Start
Apr 2014
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of Hepatitis B vaccine, infliximab and adalimumab in hepatitis B (HBV) (2 arms), sponsored by Erasmus MC. Started Apr 2014; status: recruiting.

02

Drugs

Hepatitis B vaccineinfliximabadalimumab
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NL-OMON20411.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20411.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call